HRP20120517T1 - Postupak priprave derivata halobifenil ilciklopropanekarboksilne kiseline - Google Patents

Postupak priprave derivata halobifenil ilciklopropanekarboksilne kiseline Download PDF

Info

Publication number
HRP20120517T1
HRP20120517T1 HRP20120517AT HRP20120517T HRP20120517T1 HR P20120517 T1 HRP20120517 T1 HR P20120517T1 HR P20120517A T HRP20120517A T HR P20120517AT HR P20120517 T HRP20120517 T HR P20120517T HR P20120517 T1 HRP20120517 T1 HR P20120517T1
Authority
HR
Croatia
Prior art keywords
compound
formula
fluoro
dichloro
biphenyl
Prior art date
Application number
HRP20120517AT
Other languages
English (en)
Inventor
Benoit@Folleas
Hubert@Botte
Thomas@Delacroix
Fausto@Pivetti
Original Assignee
Chiesi@Farmaceutici@S@P@A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi@Farmaceutici@S@P@A filed Critical Chiesi@Farmaceutici@S@P@A
Publication of HRP20120517T1 publication Critical patent/HRP20120517T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/26Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/263Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/093Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/10Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
    • C07C17/14Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms in the side-chain of aromatic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/14Preparation of carboxylic acid nitriles by reaction of cyanides with halogen-containing compounds with replacement of halogen atoms by cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Postupak priprave spoja opće formule I I u kojojX jest fluor tepredstavlja jedan ili više atoma halogena naznačen time da rečeni postupak obuhvaća sljedeće korake i reakcija spoja formule II II u kojoj je X gore definiran a X je odabran iz sljedeće skupine klor brom jod te triflatna skupina CF SO sa spojem formule III III u kojoj je R kao što je gore definiran i nastaje spoj formule IV IV ii podvrgavanje spoja formule IV radikalskom bromiranju pri čemu nastaje spoj formule V V iii pretvorba spojaformule V u odgovarajući nitrilni derivat spojaformule VI VI iv reakcija spoja formule VI sa dibrometanom čime nastaje spoj formuleVII te VI hidroliza spoja formule VII pri čemu nastaje spoj formule I Patent sadrži još patentnih zahtjeva

Claims (10)

1. Postupak priprave spoja opće formule (I) [image] (I) u kojoj X jest fluor, te predstavlja jedan ili više atoma halogena, naznačen time da rečeni postupak obuhvaća sljedeće korake: (i) reakcija spoja formule (II), [image] (II) u kojoj je X gore definiran, a X' je odabran iz sljedeće skupine: klor, brom, jod te triflatna skupina (CF3SO3), sa spojem formule (III) [image] (III) u kojoj je R kao što je gore definiran i nastaje spoj formule (IV), [image] (IV) (ii) podvrgavanje spoja formule (IV) radikalskom bromiranju pri čemu nastaje spoj formule (V); [image] (V) (iii) pretvorba spoja formule (V) u odgovarajući nitrilni derivat spoja formule (VI), [image] (VI) (iv) reakcija spoja formule (VI) sa 1,2-dibrometanom čime nastaje spoj formule (VII), te [image] (VI) (v) hidroliza spoja formule (VII) pri čemu nastaje spoj formule (I).
2. Postupak kako je prijavljen u patentnom zahtjevu 1, naznačen time da nadalje obuhvaća korake izolacije i kristalizacije spoja formule (I).
3. Postupak prema patentnom zahtjevu 2, naznačen time da se kristalizacija izvodi korištenjem smjese n-heptana i izopropanola.
4. Postupak kako je prijavljen u patentnim zahtjevima 1 do 3, naznačen time da se korak (i) provodi u prisutnosti paladija kao katalizatora odabranog od sljedećih: tetrakis(trifenilfosfin)paladj, paladij na aktivnom ugljenu ili paladij na aluminijevom oksidu.
5. Postupak kako je prijavljen u patentnom zahtjevu 4, naznačen time da paladij kao katalizator jest paladij na aktivnom ugljenu.
6. Postupak kako je prijavljen u bilo kojem od prethodnih patentnih zahtjeva, naznačen time da se korak (ii) provodi s N-bromsukcinimidom u prisutnosti katalitičke količine benzoil-peroksida u acetonitrilu kao otapalu.
7. Postupak kako je prijavljen u patentnom zahtjevu 1, naznačen time da halogen jest atom klora.
8. Postupak kako je prijavljen u patentnom zahtjevu 7, naznačen time da spoj formule (I) jest 1-(3’,4’-diklor-2-fluor[1,1’-bifenil]-4-il)-ciklopropankarboksilna kiselina.
9. Postupak kako je prijavljen u patentnom zahtjevu 8, naznačen time da obuhvaća sljedeće korake: (i) reakcija 4-brom-3-fluor-toluena sa 3,4-diklorfenilbornom kiseliom kojom nastaje 3’,4’-diklor-2-fluor-4-metil-bifenil, (ii) podvrgavanje 3’,4’-diklor-2-fluor-4-metil-bifenila radikalskom bromiranju pri čemu nastaje 3’,4’-diklor-2-fluor-4-metil-bifenil, (iii) pretvorba 3’,4’-diklor-2-fluor-4-metil-bifenila u odgovarajući 3’,4’-diklor-2-fluor-4-cijanometil-bifenil, (iv) reakcija 3’,4’-diklor-2-fluor-4-cijanometil-bifenila sa 1,2-dibrometanom pri čemu nastaje 1-(3’,4'-diklor-2-fluor[1,1’-bifenil]-4-il)-ciklopropanonitril, te (v) hidrolizia 1-(3’,4'-diklor-2-fluor[1,1’-bifenil]-4-il)-ciklopropanonitrila pri čemu nastaje 1-(3’,4’-diklor-2-fluor[1,1’-bifenil]-4-il)-ciklopropankarboksilna kiselina.
10. Postupak priprave farmaceutskog pripravka koji obuhvaća korake (i)-(v) iz patentnog zahtjeva 1, naznačen time da je dodatni korak (iv) obuhvaća smjesu s jednim ili više farmaceutski prihvatljivim ekscipijensima.
HRP20120517AT 2008-06-11 2012-06-20 Postupak priprave derivata halobifenil ilciklopropanekarboksilne kiseline HRP20120517T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08158022A EP2133322A1 (en) 2008-06-11 2008-06-11 Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
PCT/EP2009/003288 WO2009149797A1 (en) 2008-06-11 2009-05-08 Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid

Publications (1)

Publication Number Publication Date
HRP20120517T1 true HRP20120517T1 (hr) 2012-07-31

Family

ID=40120119

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20120517AT HRP20120517T1 (hr) 2008-06-11 2012-06-20 Postupak priprave derivata halobifenil ilciklopropanekarboksilne kiseline

Country Status (28)

Country Link
US (1) US8076505B2 (hr)
EP (2) EP2133322A1 (hr)
JP (1) JP5642067B2 (hr)
KR (1) KR101257217B1 (hr)
CN (1) CN102046576B (hr)
AT (1) ATE552230T1 (hr)
AU (1) AU2009256959B2 (hr)
BR (1) BRPI0909560A2 (hr)
CA (1) CA2723878C (hr)
CO (1) CO6331461A2 (hr)
DK (1) DK2285765T3 (hr)
ES (1) ES2384368T3 (hr)
GE (1) GEP20135800B (hr)
HK (1) HK1152292A1 (hr)
HR (1) HRP20120517T1 (hr)
IL (1) IL209209A (hr)
MA (1) MA32297B1 (hr)
ME (1) ME01160B (hr)
MX (1) MX2010012285A (hr)
MY (1) MY150280A (hr)
NZ (1) NZ589087A (hr)
PL (1) PL2285765T3 (hr)
PT (1) PT2285765E (hr)
RU (1) RU2502721C2 (hr)
SI (1) SI2285765T1 (hr)
UA (1) UA101835C2 (hr)
WO (1) WO2009149797A1 (hr)
ZA (1) ZA201007977B (hr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101088272B1 (ko) * 2003-02-21 2011-11-30 키에시 파르마슈티시 엣스. 피. 에이. 신경 퇴행성 질환의 치료를 위한 1-페닐알캔카복실산추출물
PT2462098E (pt) * 2009-08-04 2013-12-04 Chiesi Farma Spa Processos para a preparação de derivados de ácido 1-(2- halobifenil-4-il)-ciclopropanocarboxílico
CN106431900A (zh) 2010-04-01 2017-02-22 奇斯药制品公司 新的多晶型物和盐
ES2526522T3 (es) * 2010-04-21 2015-01-13 Chiesi Farmaceutici S.P.A. Derivados del ácido 1-(2-fluorobifenil-4-il)alquil carboxílico para la terapia de la amiloidosis transtiretina
CA2801449A1 (en) 2010-06-04 2011-12-08 Chiesi Farmaceutici S.P.A. 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the therapy of prion diseases
US9592210B2 (en) 2011-12-22 2017-03-14 Chiesi Farmaceutici S.P.A. 1-phenylalkanecarboxylic acid derivatives for the treatment of cognitive impairment
CA2869418A1 (en) 2012-04-04 2013-10-10 Chiesi Farmaceutici S.P.A. Derivatives of 1-(2-halo-biphenyl-4-yl)- alkanecarboxylic acids for the treatment of neurodegenerative diseases
EP2818460A1 (en) 2013-06-24 2014-12-31 ZaCh System S.p.A. Cyclopropanation of substituted phenylacetonitriles or phenyl acetates
RU2015153818A (ru) 2013-06-24 2017-06-21 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Усовершенствованный способ получения производных 1-(2-фтор[1, 1-бифенил]-4-ил)-циклопропанкарбоновой кислоты
US20150335596A1 (en) 2014-05-26 2015-11-26 Chiesi Farmaceutici S.P.A. 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the treatment of down's syndrome
CN107698462A (zh) * 2017-10-10 2018-02-16 重庆科脉生物化工有限公司 一种1‑氨基‑1‑环丙腈盐酸盐的制备方法
AU2022338032A1 (en) 2021-08-31 2024-03-07 Cerespir Incorporated Co-crystals

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4507294B2 (ja) * 1999-05-27 2010-07-21 チッソ株式会社 ビアリール誘導体の製造方法
JP4502293B2 (ja) * 1999-06-04 2010-07-14 長瀬産業株式会社 軸不斉を有する光学活性な4級アンモニウム塩、その製法およびα−アミノ酸誘導体の不斉合成への応用
JP2004091342A (ja) * 2002-08-29 2004-03-25 Matsushita Electric Ind Co Ltd 芳香族メチリデン化合物、それを製造するための化合物、それらの製造方法、及び芳香族メチリデン化合物を用いた有機電界発光素子
ITMI20030311A1 (it) * 2003-02-21 2004-08-22 Chiesi Farma Spa Acidi 2-fenil-2-dialchil-acetici per il trattamento della malattia di alzheimer.
KR101088272B1 (ko) 2003-02-21 2011-11-30 키에시 파르마슈티시 엣스. 피. 에이. 신경 퇴행성 질환의 치료를 위한 1-페닐알캔카복실산추출물
EP1650183A1 (en) * 2004-10-21 2006-04-26 Cellzome Ag (Benzyloxy-biphenyl) acetic acids and derivatives thereof and their use in therapy
US7524870B2 (en) * 2004-12-03 2009-04-28 Hoffmann-La Roche Inc. Biaryloxymethylarenecarboxylic acids as glycogen synthase activators
JP2008546651A (ja) * 2005-06-14 2008-12-25 メルク フロスト カナダ リミテツド モノアミンオキシダーゼa及びbの可逆的阻害剤
JP5272345B2 (ja) * 2006-08-28 2013-08-28 東ソー株式会社 ヘテロアセン誘導体、テトラハロターフェニル誘導体及びそれらの製造方法
PT2462098E (pt) * 2009-08-04 2013-12-04 Chiesi Farma Spa Processos para a preparação de derivados de ácido 1-(2- halobifenil-4-il)-ciclopropanocarboxílico

Also Published As

Publication number Publication date
KR101257217B1 (ko) 2013-04-22
MY150280A (en) 2013-12-31
MA32297B1 (fr) 2011-05-02
WO2009149797A1 (en) 2009-12-17
SI2285765T1 (sl) 2012-08-31
JP5642067B2 (ja) 2014-12-17
IL209209A0 (en) 2011-01-31
CA2723878C (en) 2016-06-28
EP2285765B1 (en) 2012-04-04
US8076505B2 (en) 2011-12-13
UA101835C2 (uk) 2013-05-13
AU2009256959B2 (en) 2014-03-27
NZ589087A (en) 2012-03-30
RU2010146299A (ru) 2012-07-20
US20090312426A1 (en) 2009-12-17
ME01160B (me) 2013-03-20
PT2285765E (pt) 2012-06-21
EP2133322A1 (en) 2009-12-16
CA2723878A1 (en) 2009-12-17
CN102046576B (zh) 2013-08-21
ES2384368T3 (es) 2012-07-04
MX2010012285A (es) 2010-12-01
CO6331461A2 (es) 2011-10-20
BRPI0909560A2 (pt) 2015-09-22
RU2502721C2 (ru) 2013-12-27
KR20110010633A (ko) 2011-02-01
PL2285765T3 (pl) 2012-08-31
ZA201007977B (en) 2012-02-29
CN102046576A (zh) 2011-05-04
DK2285765T3 (da) 2012-06-04
HK1152292A1 (en) 2012-02-24
AU2009256959A1 (en) 2009-12-17
GEP20135800B (en) 2013-04-10
JP2011523953A (ja) 2011-08-25
IL209209A (en) 2014-05-28
EP2285765A1 (en) 2011-02-23
ATE552230T1 (de) 2012-04-15

Similar Documents

Publication Publication Date Title
HRP20120517T1 (hr) Postupak priprave derivata halobifenil ilciklopropanekarboksilne kiseline
HRP20140032T1 (hr) Postupak priprave derivata 1-(2-halobifenil-4-il)-ciklopropankarboksilne kiseline
MX2009002967A (es) Proceso integrado para producir 2, 3, 3, 3-tetrafluoropropeno.
RU2014149148A (ru) Способ получения соединений 2-дезокси-2-фтор-2-метил-d-рибофуранозил нуклеозида
CN105439835B (zh) 一种全氟己酮的制备方法
IL266718A (en) Process for the preparation of methyl pyridine dicarboxylate
Volodin et al. Nucleophilic difluoro (trimethylsilyl) methylation of arylidene Meldrum's acids
Vasilevsky et al. One-pot synthesis of monosubstituted aryl (hetaryl) acetylenes by direct introduction of the C CH residue into arenes and hetarenes
JP5959467B2 (ja) 2−フルオロ−1,3−ジカルボニル化合物の製造方法
JP2017128525A (ja) 含フッ素化合物の製造方法
Karur et al. A novel approach to Morita–Baylis–Hillman (MBH) lactones via the Lewis acid-promoted couplings of α, β-unsaturated lactone with aldehydes
CN105801577B (zh) 一种多氟甲基取代的吡咯[3,2‑c]并喹啉类化合物的制备方法
JP2010248177A (ja) シクロプロパンカルボン酸エステルの製造方法
US6770788B2 (en) Process and intermediate compounds for preparation of pesticidal fluoroolefin compounds
Choi et al. Cross-coupling Reaction of β, β-Difluoro-α-phenylvinylstannane with Alkenyl Iodides: Novel Approach to 2-Phenyl-1, 1-difluoro-1, 3-butadienes
TAKAGI et al. A method for synthesis of fluorine compounds using abnormal Grignard reaction of halothane. III. Simple synthesis of trifluoromethylchloroolefins
Mohanakrishnan et al. Unusual dimerization of N-protected bromomethylindoles using phenylmagnesium chloride
BR0115351A (pt) Processo para preparar derivados de distamicina
EP3268346A1 (en) Processes for the preparation of unsaturated malonates
Heredia et al. 1-Bromo-2, 4-dihydro-1H-pyrazino [2, 1-b] quinazoline-3, 6-diones as α-bromoglycine templates
JP2020125282A (ja) 含フッ素化合物の製造方法
CN110256247A (zh) 2-((9-氢芴-9-基)甲基)丙二酸酯的合成方法
JP2011219394A (ja) α,β−不飽和エステルの製造方法
JP2011016738A (ja) (メタ)アクリル酸エステル化合物の製造方法
CN110256274A (zh) 一种制备n-甲基-n-苯基-2,3-二溴-3-取代苯基丙酰胺类化合物的方法